Fragile X syndrome is almost always caused by the absence or deficit of the
FMR1 protein (FMRP). Diagnostic methods include polymerase chain reaction
and Southern blotting, which are performed on DNA isolated from peripheral
leukocytes. Recently, different immunocytochemical tests have been describe
d to identify patients with fragile X syndrome, based on the detection of F
MRP in cells by a monoclonal antibody. This review aims to provide an updat
e on the different antibody methods for prenatal and postnatal diagnosis of
the fragile X syndrome. Am. J. Med. Genet. (Semin. Med. Genet.) 97:183-188
, 2000. (C) 2000 Wiley-Liss, Inc.